Seiwert TY - Search Results

1

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.

Cohen EE, Karrison TG, Kocherginsky M, Mueller J, Egan R, Huang CH, Brockstein BE, Agulnik MB, Mittal BB, Yunus F, Samant S, Raez LE, Mehra R, Kumar P, Ondrey F, Marchand P, Braegas B, Seiwert TY, Villaflor VM, Haraf DJ, Vokes EE. Cohen EE, et al. Among authors: seiwert ty. J Clin Oncol. 2014 Sep 1;32(25):2735-43. doi: 10.1200/JCO.2013.54.6309. Epub 2014 Jul 21. J Clin Oncol. 2014. PMID: 25049329 Free PMC article. Clinical Trial.

2

State-of-the-art management of locally advanced head and neck cancer.

Seiwert TY, Cohen EE. Seiwert TY, et al. Br J Cancer. 2005 Apr 25;92(8):1341-8. doi: 10.1038/sj.bjc.6602510. Br J Cancer. 2005. PMID: 15846296 Free PMC article. Review.

3

A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.

Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ, Vokes EE. Seiwert TY, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):515-22. doi: 10.1158/1078-0432.CCR-06-1058. Clin Cancer Res. 2007. PMID: 17255273 Clinical Trial.

4

The concurrent chemoradiation paradigm--general principles.

Seiwert TY, Salama JK, Vokes EE. Seiwert TY, et al. Nat Clin Pract Oncol. 2007 Feb;4(2):86-100. doi: 10.1038/ncponc0714. Nat Clin Pract Oncol. 2007. PMID: 17259930 Review.

5

The chemoradiation paradigm in head and neck cancer.

Seiwert TY, Salama JK, Vokes EE. Seiwert TY, et al. Nat Clin Pract Oncol. 2007 Mar;4(3):156-71. doi: 10.1038/ncponc0750. Nat Clin Pract Oncol. 2007. PMID: 17327856 Review.

6

Chemoradiotherapy for locally advanced head and neck cancer.

Salama JK, Seiwert TY, Vokes EE. Salama JK, et al. Among authors: seiwert ty. J Clin Oncol. 2007 Sep 10;25(26):4118-26. doi: 10.1200/JCO.2007.12.2697. J Clin Oncol. 2007. PMID: 17827462 Review. No abstract available.

7

A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.

Seiwert TY, Cohen EE, Haraf DJ, Stenson K, Blair EA, Mauer A, Dekker A, Vokes EE. Seiwert TY, et al. Cancer Invest. 2007 Sep;25(6):435-44. doi: 10.1080/07357900701357993. Cancer Invest. 2007. PMID: 17882655 Clinical Trial.

8

Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.

Seiwert TY, Haraf DJ, Cohen EE, Stenson K, Witt ME, Dekker A, Kocherginsky M, Weichselbaum RR, Chen HX, Vokes EE. Seiwert TY, et al. J Clin Oncol. 2008 Apr 1;26(10):1732-41. doi: 10.1200/JCO.2007.13.1706. J Clin Oncol. 2008. PMID: 18375903 Clinical Trial.

9

Targeting angiogenesis in head and neck cancer.

Seiwert TY, Cohen EE. Seiwert TY, et al. Semin Oncol. 2008 Jun;35(3):274-85. doi: 10.1053/j.seminoncol.2008.03.005. Semin Oncol. 2008. PMID: 18544442 Review.

10

Protein kinase C beta in malignant pleural mesothelioma.

Faoro L, Loganathan S, Westerhoff M, Modi R, Husain AN, Tretiakova M, Seiwert T, Kindler HL, Vokes EE, Salgia R. Faoro L, et al. Anticancer Drugs. 2008 Oct;19(9):841-8. doi: 10.1097/CAD.0b013e32830ce506. Anticancer Drugs. 2008. PMID: 18765998 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page